This is a curator-written synthesis of the sources identified below. It was not generated by a deep-research provider. The source guide records which original sections, abstracts and model objects were actually inspected; a full-text cache flag is not a claim that every experiment was read.
GATA2 is a nuclear, sequence-specific RNA polymerase II transcription factor. The early human study reports that “expressed human GATA-2 protein transactivates reporter gene constructs” (PMID:1370462(https://pubmed.ncbi.nlm.nih.gov/1370462/)). Human endothelial GATA-site reporter and EMSA experiments, endogenous promoter occupancy and context-dependent transcriptional partners support activation and repression. DNA recognition and partner recruitment contribute to the same transcriptional activity; generic interaction-screen positives do not establish additional molecular functions (PMID:15016828(https://pubmed.ncbi.nlm.nih.gov/15016828/), PMID:21788589(https://pubmed.ncbi.nlm.nih.gov/21788589/), PMID:23887938(https://pubmed.ncbi.nlm.nih.gov/23887938/)).
Human GATA2–PML association and reporter potentiation support coactivator binding, with the tested cellular and construct limits retained. FOG2 instead provides a coregulator-binding context: human GATA2 and FOG2 contact mutants in mouse 3T3-L1 cells alter differentiation and proliferation, with residual activities and expression controls. These experiments support functional interface dependence, not a new purified-affinity measurement or transfer of CTBP catalysis to GATA2 (PMID:10938104(https://pubmed.ncbi.nlm.nih.gov/10938104/), PMID:20705609(https://pmc.ncbi.nlm.nih.gov/articles/PMC2952242/)).
GATA2 helps instruct cell-fate programs, including experimentally induced eosinophil differentiation. Human primary recipients and mouse constructs or experiments are distinguished. Rat dorsal-midbrain/superior-colliculus knockdown and human GATA2 rescue support neuronal migration and differentiation, whereas the separate PC12 neurite assay has a different directional outcome. Disease association alone is not used to add a process (PMID:12045236(https://pmc.ncbi.nlm.nih.gov/articles/PMC2193540/), PMID:21430145(https://pubmed.ncbi.nlm.nih.gov/21430145/)).
In endothelial cells, GATA2 contributes to HMOX1 and VEGFR2 regulation and vessel formation. Selected authentic original Methods/Results support GATA2 perturbation and rescue; the 22499991 cache itself omits those main sections. Human dermal-cell experiments and mouse miRNA/TNF wound interventions provide complementary but distinct evidence for vascular repair. The narrower source-specific migration readout remains unresolved, and a Discussion citation to prior migration work is not treated as a newly inspected assay (PMID:21788589(https://pubmed.ncbi.nlm.nih.gov/21788589/), PMID:22499991(https://pmc.ncbi.nlm.nih.gov/articles/PMC3399424/)).
The authentic 27780851 abstract reports GATA2-dependent miR-126 transcription in human umbilical-vein endothelial cells. That claim is accepted across its matching IDA and IGI contexts; the detailed Q96SQ7 genetic interaction remains unverified. The same abstract does not resolve every alternate target, migration, proliferation or localization experiment. Similarly, ADH1A cis-element reporter and GATA2 DNA-shift evidence supports positive transcriptional regulation without establishing a GATA2–ADH1A protein interaction (PMID:27780851(https://pubmed.ncbi.nlm.nih.gov/27780851/), PMID:16153155(https://pubmed.ncbi.nlm.nih.gov/16153155/)).
The verified natural products contain 480 and 466 residues; the shorter lacks canonical residues 340–353. Sequence reconstruction alone does not establish different physiological functions. Matched-abundance comparisons of DNA recognition, partner recruitment and localization remain useful experiments. The review retains all original contexts, including the four alternative target-expression groups that the flat annotation-extension schema cannot represent.